Shortystrap Effectiveness in the Treatment of the Pathology Pubic and Abdominal Pathology in Athletes

NCT ID: NCT02882399

Last Updated: 2019-09-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

49 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-04-12

Study Completion Date

2015-11-06

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The pubic and abdominal pathology is common among athletes. It leads to a shutdown of physical activity for several months, and requires rehabilitative care, or surgery for a permanent cure. Shortystrap is designed to avoid surgery and allow the continuation of sports.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pubic and Abdominal Pathology

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Shortystrap

Group Type EXPERIMENTAL

Shortystrap

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Shortystrap

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male
* Sports practicing physical activity at least 3 hours per week
* Practicing a team sport with a major part of running (football, rugby, ...)
* Presenting a pubic and abdominal pathology for at least 4 weeks
* In primary consultation
* Age from 18 to 40 years
* Informed consent signed

Exclusion Criteria

* Professional athlete
* Cyclist
* Having already received usual medical treatment (anti-inflammatory treatment and rest)
* Introducing another disease requiring treatment with NSAIDs
* Allergy neoprene
* Contraindications to performing MRI (claustrophobia, any metal device, pacemaker, etc.)
* Simultaneous participation in another biomedical research
* Major person under legal protection (backup justice, trusteeship, guardianship), person deprived of liberty.
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Rennes University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Pierrick GUILLEMOT, Md

Role: STUDY_DIRECTOR

CHU Rennes

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU Rennes

Rennes, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

35RC12_8971

Identifier Type: OTHER

Identifier Source: secondary_id

2012-A01172-41

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.